Valuation: Proto Script Pharmaceutical Corp.

Market Cap 19.66L 17.46L 16.3L 14.86L 28.02L 19Cr 28.28L 1.97Cr 76.44L 9.66Cr 73.8L 72.2L 31Cr P/E 2015 *
-
P/E 2016 -41.4x
Enterprise Value 20.13L 17.89L 16.7L 15.22L 28.7L 19Cr 28.97L 2.02Cr 78.3L 9.89Cr 75.59L 73.95L 32Cr EV / Sales 2015 *
-
EV / Sales 2016 394x
Free-Float
89.82%
Yield 2015 *
-
Yield 2016 -
Current year 0
Extreme 0.0001
0
1 year 0
Extreme 0.0001
0
3 years 0
Extreme 1.0E-6
0
5 years 0
Extreme 1.0E-6
0.02
10 years 0
Extreme 1.0E-6
2.2
Manager TitleAgeSince
Chief Executive Officer 58 29/06/2016
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--%-.--%-98.00% 5.69T
+0.23%-1.83%+3.09%+55.98% 66TCr
-1.32%-3.45%-4.73%+59.54% 7.71TCr
+4.54%+3.25%+10.22%+154.87% 6.73TCr
+4.53%+2.31%+89.72%+1,182.00% 6.66TCr
-0.49%-4.07%-23.75%-9.85% 4.52TCr
+0.39%-2.73%-3.40%+77.40% 4.49TCr
+1.97%+2.72%+13.11%+33.85% 3.16TCr
+1.25%-0.88%+36.86%+57.01% 2.59TCr
-2.25%-4.56%-65.22%-60.73% 2.36TCr
Average +0.88%-0.92%+5.59%+145.21% 10.44TCr
Weighted average by Cap. +0.67%-1.39%+6.65%+129.18%

Financials

2015 2016
Net sales 9L 8L 7L 7L 12.57L 8.47Cr 12.68L 88.46L 34.28L 4.33Cr 33.09L 32.38L 14Cr 8L 7L 7L 6L 11.25L 7.58Cr 11.35L 79.18L 30.68L 3.88Cr 29.62L 28.98L 12Cr
Net income -1L -1L -1L -1L -2L -1.4Cr -2L -14.58L -6L -71.38L -5L -5L -2.29Cr -71.83L -63.82L -59.56L -54.29L -1.02Cr -69Cr -1.03Cr -7.21Cr -2.79Cr -35Cr -2.7Cr -2.64Cr -113.29Cr
Net Debt 27.07T 24.05T 22.45T 20.46T 38.59T 26.02L 38.95T 3L 1L 13.3L 1L 99.42T 42.69L 47.78T 42.46T 39.63T 36.12T 68.12T 45.94L 68.75T 5L 2L 23.48L 2L 2L 75.36L
Logo Proto Script Pharmaceutical Corp.
Proto-Script Pharmaceuticals, Corp., formerly Yanex Group, Inc. is a development-stage company. The Company is primarily in the business of repair power wheelchairs and scooters, which are classified as durable medical equipment (DME) products and reimbursable by healthcare insurance providers. The Company has various contracts with state and governmental insurance providers, among others. These contracts provide the Company the right to sell and repair DME. The Company's health care insurance contracts allow it the ability to service patients nationally. The Company intends to expand its market through additional contracts and open several repair facilities throughout the continental United States. The Company currently has repair facilities in Las Vegas, Nevada, Rancho-Cucamonga, and Anaheim, California. As of June 30, 2016, the Company had not generated any revenues.
Employees
13
  1. Stock Market
  2. Stocks
  3. PSCR Stock